Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis-Reference-Cited by-同舟云学术

Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis

Published:2002-10 Issue:10 Volume:32 Page:1448-1453
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:

Author:

Van Hage-Hamsten M.,Johansson E.,Roquet A.,Peterson C.,Andersson M.,Greiff L.,Vrtala S.,Valenta R.,Grönneberg R.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2745.2002.01495.x/fullpdf

Reference30 articles.

1. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper;Bousquet;Allergy,1998

2. Immunological changes associated with allergen immunotherapy;Durham;J Allergy Clin Immunol,1998

3. Role of interleukin 10 in specific immunotherapy;Akdis;J Clin Invest,1998

4. Recombinant allergens for diagnosis and therapy of allergic disease;Chapman;J Allergy Clin Immunol,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasal IL-13 production identifies patients with late-phase allergic responses;Journal of Allergy and Clinical Immunology;2023-11

2. Allergen Homologues, Pathogenesis-Related 1, Polygalacturonase, and Pectin Methyl Esterase from a Japanese Hop;Protein & Peptide Letters;2021-05-19

3. Mucosal Vaccines for Allergy and Tolerance;Mucosal Vaccines;2020

4. Precision medicine allergy immunoassay methods for assessing immunoglobulin E sensitization to aeroallergen molecules;World Journal of Methodology;2018-11-29

5. Next generation immunotherapy for tree pollen allergies;Human Vaccines & Immunotherapeutics;2017-10-03